眼部疾病
Retinal Diseases

在百靈佳殷格翰，我們針對造成視力障礙與失明的眼部疾病擴大了全球研發行動。視力障礙和失明對受影響人的家庭和整個社會的生活產生了破壞性衝擊。在熱情的推動下，我們透過開發新的治療方法和技術來改變視網膜健康格局，我們的目標很明確——預防高危人群的視力喪失，保護或恢復視網膜疾病患者的視力。科學和創新是我們建立眼部健康領域發展可能的核心，第一輪臨床開發已經展開。

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye. Visual impairment and blindness have a profound and devastating impact on the lives of the affected person, their families and society as a whole. Driven by our passion to improve care, we will transform the retinal health landscape by developing novel treatments and technologies, especially where nothing currently exists. Our ambition is clear - prevent vision loss in people at risk and preserve or restore vision in those with retinal diseases. Science and innovation are at the core of the comprehensive pipeline portfolio we have built in Retinal Health, with the first assets already in clinical development.